HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Mohammad B. Izzat Gianni D. Angelini Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Izzat, M. B. Articles by Angelini, G. D. Search for Related Content PubMed PubMed Citation Articles by Izzat, M. B. Articles by Angelini, G. D.

J Thorac Cardiovasc Surg 1994;108:82-85
© 1994 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Effect of systemic vasodilators on internal mammary artery flowImplications for postoperative treatment after myocardial revascularization

Bristol and Cardiff, United Kingdom

Received for publication Sept. 8, 1993. Accepted for publication Jan. 18, 1994. Address for reprints: G.D. Angelini, MD, Professor of Cardiac Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom.

Abstract

Postoperative spasm of the internal mammary artery graft can cause morbidity and mortality after myocardial revascularization. To our knowledge, the ability of systemic vasodilators to overcome internal mammary artery spasm has not been studied clinically. In 50 patients in whom the left internal mammary artery was used for myocardial revascularization, we have investigated the effect of five agents on internal mammary artery free flow: normal saline, dobutamine, glyceryl trinitrate, sodium nitroprusside, and enoximone, a phosphodiesterase III inhibitor. After the internal mammary artery was harvested, free flow was measured under controlled hemodynamic conditions before any pharmacologic intervention (flow 1) and a mean of 18.5 ± 3 (standard deviation) minutes after a systemic infusion of one of the five agents was begun (flow 2). The increase in free flow expressed as a percentage of initial flow was greater for enoximone (94% ± 24%) than for normal saline (18% ± 11%), dobutamine (40% ± 27%), and glyceryl trinitrate (52% ± 36%) (all three p < 0.01). The increase in flow for sodium nitroprusside (78% ± 37%) was greater than for normal saline and dobutamine (both p < 0.05). We therefore recommend the systemic use of enoximone and sodium nitroprusside, in rank order, to prevent and treat postoperative spasm of the internal mammary artery. (J THORAC CARDIOVASC SURG 1994;108:82-5)

This article has been cited by other articles:

				G.-W. He, L. Fan, A. Furnary, and Q. Yang A new antispastic solution for arterial grafting: Nicardipine and nitroglycerin cocktail in preparation of internal thoracic and radial arteries for coronary surgery J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 673 - 680. [Abstract] [Full Text] [PDF]

				C. Izumi, H. Hayashi, Y. Ueda, M. Matsumoto, Y. Himura, H. Gen, and T. Konishi Late regression of left internal thoracic artery graft stenosis at the anastomotic site without intervention therapy J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1661 - 1667. [Abstract] [Full Text] [PDF]

				Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, Z. Elar, and O. Aslan Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 553 - 559. [Abstract] [Full Text] [PDF]

				M. J. Flynn, D. Winters, P. Breen, G. O'Sullivan, G. Shorten, D. O'Connell, A. O'Donnell, and T. Aherne Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 547 - 551. [Abstract] [Full Text] [PDF]

				M.-H. Liu, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery Ann. Thorac. Surg., February 1, 2001; 71(2): 636 - 641. [Abstract] [Full Text] [PDF]

				D. Zabeeda, B. Medalion, S. Jackobshvilli, S. Ezra, A. Schachner, and A. J. Cohen Comparison of systemic vasodilators: effects on flow in internal mammary and radial arteries Ann. Thorac. Surg., January 1, 2001; 71(1): 138 - 141. [Abstract] [Full Text] [PDF]

				M. B. Vroom Pharmacologic Management of Acute Heart Failure: A Review Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 191 - 203. [Abstract] [PDF]

				J.-L. Cracowski, O. Chavanon, M. Durand, E. Borrel, P. Devillier, J.-M. Mallion, and D. Blin Effect of Low-Dose Positive Inotropic Drugs on Human Internal Mammary Artery Flow Ann. Thorac. Surg., December 1, 1997; 64(6): 1742 - 1746. [Abstract] [Full Text]

				M. B. Izzat, S. Bolsin, A. J. Bryan, and G. D. Angelini Enoximone in internal mammary artery hypoperfusion J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 868 - 870. [Full Text]